Literature DB >> 33530406

What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?

Piotr Schulz1,2, Szymon Hryhorowicz3, Anna Maria Rychter1, Agnieszka Zawada1, Ryszard Słomski3, Agnieszka Dobrowolska1, Iwona Krela-Kaźmierczak1.   

Abstract

The endocannabinoid system (ECS) is an endogenous signaling system formed by specific receptors (cannabinoid type 1 and type 2 (CB1 and CB2)), their endogenous ligands (endocannabinoids), and enzymes involved in their synthesis and degradation. The ECS, centrally and peripherally, is involved in various physiological processes, including regulation of energy balance, promotion of metabolic process, food intake, weight gain, promotion of fat accumulation in adipocytes, and regulation of body homeostasis; thus, its overactivity may be related to obesity. In this review, we try to explain the role of the ECS and the impact of genetic factors on endocannabinoid system modulation in the pathogenesis of obesity, which is a global and civilizational problem affecting the entire world population regardless of age. We also emphasize that the search for potential new targets for health assessment, treatment, and the development of possible therapies in obesity is of great importance.

Entities:  

Keywords:  cannabinoid receptors; endocannabinoid system; obesity; obesity genes; obesity pathogenesis

Mesh:

Substances:

Year:  2021        PMID: 33530406      PMCID: PMC7911032          DOI: 10.3390/nu13020373

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  212 in total

1.  Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.

Authors:  Douglas Osei-Hyiaman; Michael DePetrillo; Pál Pacher; Jie Liu; Svetlana Radaeva; Sándor Bátkai; Judith Harvey-White; Ken Mackie; László Offertáler; Lei Wang; George Kunos
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 2.  Rimonabant: endocannabinoid inhibition for the metabolic syndrome.

Authors:  A S Wierzbicki
Journal:  Int J Clin Pract       Date:  2006-12       Impact factor: 2.503

3.  No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents.

Authors:  Timo Dirk Müller; Kathrin Reichwald; Anne-Kathrin Wermter; Günter Brönner; Thuy Trang Nguyen; Susann Friedel; Kerstin Koberwitz; Stefan Engeli; Peter Lichtner; Thomas Meitinger; Helmut Schäfer; Johannes Hebebrand; Anke Hinney
Journal:  Mol Genet Metab       Date:  2007-02-08       Impact factor: 4.797

4.  Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.

Authors:  Amy C Porter; John-Michael Sauer; Michael D Knierman; Gerald W Becker; Michael J Berna; Jingqi Bao; George G Nomikos; Petra Carter; Frank P Bymaster; Andrea Baker Leese; Christian C Felder
Journal:  J Pharmacol Exp Ther       Date:  2002-06       Impact factor: 4.030

5.  A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes.

Authors:  M S Kipnes; P Hollander; K Fujioka; I Gantz; T Seck; N Erondu; Y Shentu; K Lu; S Suryawanshi; M Chou; A O Johnson-Levonas; S B Heymsfield; D Shapiro; K D Kaufman; J M Amatruda
Journal:  Diabetes Obes Metab       Date:  2010-06       Impact factor: 6.577

6.  Ingestion of bacterial lipopolysaccharide inhibits peripheral taste responses to sucrose in mice.

Authors:  X Zhu; L He; L P McCluskey
Journal:  Neuroscience       Date:  2013-11-09       Impact factor: 3.590

Review 7.  Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.

Authors:  Ian J Neeland; Paul Poirier; Jean-Pierre Després
Journal:  Circulation       Date:  2018-03-27       Impact factor: 29.690

8.  Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.

Authors:  Elżbieta Radziszewska; Ewa Bojanowska
Journal:  Med Sci Monit Basic Res       Date:  2013-01-01

9.  An epigenome-wide study of obesity in African American youth and young adults: novel findings, replication in neutrophils, and relationship with gene expression.

Authors:  Xiaoling Wang; Yue Pan; Haidong Zhu; Guang Hao; Yisong Huang; Vernon Barnes; Huidong Shi; Harold Snieder; James Pankow; Kari North; Megan Grove; Weihua Guan; Ellen Demerath; Yanbin Dong; Shaoyong Su
Journal:  Clin Epigenetics       Date:  2018-01-05       Impact factor: 6.551

10.  Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity.

Authors:  Timo D Müller; Günter Brönner; Melanie Wandolski; Jophia Carrie; Trang T Nguyen; Brandon H Greene; André Scherag; Harald Grallert; Carla Ig Vogel; Susann Scherag; Winfried Rief; Hans-Erich Wichmann; Thomas Illig; Helmut Schäfer; Johannes Hebebrand; Anke Hinney
Journal:  BMC Med Genet       Date:  2010-01-01       Impact factor: 2.103

View more
  7 in total

Review 1.  Cross-Talk Between Gut Microbiota and Adipose Tissues in Obesity and Related Metabolic Diseases.

Authors:  Dan Wu; Huiying Wang; Lijun Xie; Fang Hu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-05       Impact factor: 6.055

2.  Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function.

Authors:  Kieran Shay Struebin Abbotts; Taylor Russell Ewell; Hannah Michelle Butterklee; Matthew Charles Bomar; Natalie Akagi; Gregory P Dooley; Christopher Bell
Journal:  Nutrients       Date:  2022-05-21       Impact factor: 6.706

Review 3.  The Role of Nutritional Status, Gastrointestinal Peptides, and Endocannabinoids in the Prognosis and Treatment of Children with Cancer.

Authors:  Magdalena Schab; Szymon Skoczen
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

4.  Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review.

Authors:  Szymon Hryhorowicz; Marta Kaczmarek-Ryś; Aleksandra Zielińska; Rodney J Scott; Ryszard Słomski; Andrzej Pławski
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

5.  Neurohumoral Profiles and Childhood Adversity of Patients with Multisomatoform Disorder and Pain as the Leading Bodily Symptom.

Authors:  Johannes Achenbach; Lilly Volkmann; Anh-Thu Tran; Burkard Jäger; Mathias Rhein; Alexander Glahn; Michael Bernateck; Matthias Karst
Journal:  Dis Markers       Date:  2022-02-22       Impact factor: 3.434

6.  Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597.

Authors:  Marta Baranowska-Kuczko; Hanna Kozłowska; Monika Kloza; Ewa Harasim-Symbor; Michał Biernacki; Irena Kasacka; Barbara Malinowska
Journal:  Int J Mol Sci       Date:  2021-05-02       Impact factor: 5.923

Review 7.  Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review.

Authors:  Justin Matheson; Xin Ming Matthew Zhou; Zoe Bourgault; Bernard Le Foll
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.